Cases & Deals

Allergan defends JUVEDERM® patents against nine IPR petitions filed by Prollenium

Clients Allergan, Inc.

Jones Day is representing Allergan, Inc. before the U.S. Patent Trial and Appeal Board ("PTAB") on nine IPR petitions filed by Prollenium challenging multiple patents covering certain of Allergan's JUVEDERM® products, hyaluronic acid-based dermal fillers that include the anesthetic lidocaine.

Prollenium US Inc., et al. v. Allergan Industrie SAS, et al., IPR Nos. 2019-01505, -01506, -01508, -01509, -01617, -01632; 2020-00084, -00901, -00902 (PTAB)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.